OCUGEN, INC. |
Market Closed -
Other stock markets
|
After market 07:08:31 pm | |||
| 1.98 USD | +1.02% |
|
1.975 | -0.25% |
Chart calendar Ocugen, Inc.
8b45ab8a4d86c6f94f61.M5hQRq9zaoNaKnA_OUjcMQCYsJNKRDygPpyP6pr2XaI.f8kqDJsWKa4sZypWfj3uSWHQxfgPL2zrROW9pfzAE5Bh8zJymQAlrjlFJQ~8bb12b44e3ccabbb224a9932b5cec192
Upcoming events on Ocugen, Inc.
Past events on Ocugen, Inc.
| 2024-05-14 08:30 am | Q1 2024 Earnings Call |
| 2024-05-14 08:00 am | Q1 2024 Earnings Release |
| 2024-05-13 09:30 am | Citizens JMP Life Sciences Conference |
| 2024-05-09 09:05 am | Retina World Congress |
| 2024-05-08 05:00 pm | Association for Research in Vision and Ophthalmology Meeting - Booth Number: 4921 |
| 2024-05-07 05:00 pm | Association for Research in Vision and Ophthalmology Meeting - Booth Number: 4921 |
| 2024-05-06 04:00 pm | Association for Research in Vision and Ophthalmology Meeting - Booth Number: 4921 |
| 2024-05-05 04:45 pm | Association for Research in Vision and Ophthalmology Meeting - Presentation Number: 406 |
| 2024-05-03 01:50 pm | Retinal Cell and Gene Therapy Innovation Summit - Nuclear Hormone Receptor-Based Gene Modifier Thera |
| 2024-04-17 10:00 am | Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference |
| 2024-04-02 08:30 am | Q4 2023 Earnings Call |
| 2024-04-02 08:00 am | Q4 2023 Earnings Release |
| 2024-03-08 04:45 pm | Foundation Fighting Blindness Investing in Cures Summit |
| 2024-03-01 06:05 am | Abu Dhabi Family Office Summit |
| 2024-02-26 01:45 pm | BIO CEO & Investor Conference |
| 2024-02-21 10:00 am | Clinical Show |
| 2024-02-07 09:00 am | Pharma Market Research Conference |
| 2023-12-04 02:00 pm | Noble Capital Markets Emerging Growth Equity Conference |
| 2023-11-09 08:30 am | Q3 2023 Earnings Call |
| 2023-11-09 06:30 am | Q3 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,04 0,01 296.47% | 0,00 0,00 - | 0,00 2,17 - | 6,04 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,2 -12,9 -9.77% | -21,3 -15,8 -34.85% | -58,0 -54,2 -6.98% | -84,9 -82,0 -3.55% | -65,5 -72,3 9.33% | -59,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -58,4 -53,2 -9.86% | -81,4 -81,0 -0.46% | -63,1 -69,0 8.52% | -59,6 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -58,4 -53,1 -9.82% | -81,4 -81,0 -0.46% | -63,1 -69,0 8.52% | -59,6 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | -0,31 -0,36 13.89% | -0,30 -0,30 0% | -0,38 -0,38 0% | -0,26 -0,28 8.23% | -0,22 |
| Announcement Date | 27/03/20 | 18/03/21 | 25/02/22 | 28/02/23 | 16/04/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 13,8 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 2,17 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 1,42 0,00 - | 1,01 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -18,0 31,4 -157.51% | -19,6 -17,8 -10.02% | -23,1 -22,0 -5.09% | -24,2 -23,8 -1.33% | -17,8 -25,6 30.66% | -23,7 -17,7 -34.45% | -15,4 -18,9 18.35% | -11,5 -15,4 25.01% | -14,3 | -15,8 | -17,5 | |||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,0 34,0 -152.97% | -19,5 -17,8 -9.49% | -21,9 -22,0 0.35% | -21,9 -23,8 7.95% | -16,5 -25,6 35.55% | -22,9 -17,3 -32.63% | -14,2 -18,6 24.03% | -11,0 -15,4 28.63% | -14,3 | -15,8 | -17,5 | |||
|
Net income Million USD | Released Forecast Spread | -18,0 34,0 -152.97% | -19,5 -17,8 -9.49% | -21,9 -22,0 0.35% | -21,9 -23,8 7.95% | -16,5 -25,1 34.24% | -22,9 -17,3 -32.63% | -14,2 -18,6 24.03% | -11,0 -15,4 28.63% | -14,3 | -15,8 | -17,5 | |||
|
EPS USD | Released Forecast Spread | -0,09 0,01 -775.17% | -0,09 -0,08 -18.42% | -0,10 -0,10 -1.7% | -0,10 -0,10 0% | -0,07 -0,11 35.19% | -0,10 -0,07 -37.93% | -0,06 -0,07 14.29% | -0,03 -0,06 50% | -0,05 -0,06 21.05% | -0,05 | -0,05 | -0,06 | -0,07 | -0,08 |
| Announcement Date | 06/05/22 | 05/08/22 | 08/11/22 | 28/02/23 | 05/05/23 | 21/08/23 | 09/11/23 | 16/04/24 | 14/05/24 | - | - | - | - | - |
| Today 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
Past sector events for Ocugen, Inc.
| 2024-05-15 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
| 2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
| 2024-05-13 04:30 pm | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-13 07:00 am | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-12 07:00 pm | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
| 2024-05-13 06:30 am | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OCGN Stock
- Calendar Ocugen, Inc.
